-Reuters
IVERIC bio Q2 EPS $(0.32) Misses $(0.26) Estimate
IVERIC bio (NASDAQ:ISEE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.26) by 23.08 percent. This is unchanged from the same period last year.